| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |